These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24411967)

  • 1. Does take-home naloxone reduce non-fatal overdose?
    Bennett T; Holloway K; Bird SM
    Lancet; 2014 Jan; 383(9912):124-5. PubMed ID: 24411967
    [No Abstract]   [Full Text] [Related]  

  • 2. Intranasal naloxone soon to become part of evolving clinical practice around opioid overdose prevention.
    Dietze P; Cantwell K
    Addiction; 2016 Apr; 111(4):584-6. PubMed ID: 26995168
    [No Abstract]   [Full Text] [Related]  

  • 3. Radical red tape reduction by government supported nasal naloxone: the Norwegian pilot project is innovative, safe and an important contribution to further development and dissemination of take-home naloxone.
    Lobmaier PP; Clausen T
    Addiction; 2016 Apr; 111(4):586-7. PubMed ID: 26995169
    [No Abstract]   [Full Text] [Related]  

  • 4. Managing opioid overdose in pregnancy with take-home naloxone.
    Blandthorn J; Bowman E; Leung L; Bonomo Y; Dietze P
    Aust N Z J Obstet Gynaecol; 2018 Aug; 58(4):460-462. PubMed ID: 29271100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scotland's National Naloxone Programme.
    Bird SM; McAuley A
    Lancet; 2019 Jan; 393(10169):316-318. PubMed ID: 30696566
    [No Abstract]   [Full Text] [Related]  

  • 6. Challenges with take-home naloxone in reducing heroin mortality: a review of fatal heroin overdose cases in Victoria, Australia.
    Stam NC; Gerostamoulos D; Smith K; Pilgrim JL; Drummer OH
    Clin Toxicol (Phila); 2019 May; 57(5):325-330. PubMed ID: 30451007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland.
    O'Halloran C; Cullen K; Njoroge J; Jessop L; Smith J; Hope V; Ncube F
    Int J Drug Policy; 2017 Aug; 46():34-40. PubMed ID: 28586701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Quick, Grab the Naloxone": Overdose Preparedness for Ambulatory Clinics.
    Leyde S; Rife T; Kryzhanovskaya I
    Fam Pract Manag; 2021; 28(1):17-22. PubMed ID: 33433179
    [No Abstract]   [Full Text] [Related]  

  • 9. Ensure global access to naloxone for opioid overdose management.
    Balster RL; Walsh SL
    Addiction; 2016 Apr; 111(4):589-90. PubMed ID: 26995171
    [No Abstract]   [Full Text] [Related]  

  • 10. Opioid overdose prevention and naloxone rescue kits: what we know and what we don't know.
    Kerensky T; Walley AY
    Addict Sci Clin Pract; 2017 Jan; 12(1):4. PubMed ID: 28061909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Take-Home Naloxone Program Implementation: Lessons Learned From Seven Chicago-Area Hospitals.
    Eswaran V; Allen KC; Bottari DC; Splawski JA; Bains S; Aks SE; Swoboda HD; Moore PQ; Tran TH; Salisbury-Afshar E; Lank PM; McCarthy DM; Kim HS
    Ann Emerg Med; 2020 Sep; 76(3):318-327. PubMed ID: 32241746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of Southern Wisconsin Needle Exchange Clients Regarding Opioid Overdose and Naloxone Use.
    Baltes A; Devo B; Kaiser M; Birstler J; Brown RT
    WMJ; 2019 Jul; 118(2):84-87. PubMed ID: 31532934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of a naloxone dispensing program in a grocery store-based community pharmacy.
    Wilkerson DM; Groves BK; Mehta BH
    Am J Health Syst Pharm; 2020 Mar; 77(7):511-514. PubMed ID: 32086505
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom.
    Langham S; Wright A; Kenworthy J; Grieve R; Dunlop WCN
    Value Health; 2018 Apr; 21(4):407-415. PubMed ID: 29680097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overdose Education and Naloxone Distribution in the San Francisco County Jail.
    Wenger LD; Showalter D; Lambdin B; Leiva D; Wheeler E; Davidson PJ; Coffin PO; Binswanger IA; Kral AH
    J Correct Health Care; 2019 Oct; 25(4):394-404. PubMed ID: 31672075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethical issues and stakeholders matter.
    Dale O
    Addiction; 2016 Apr; 111(4):587-9. PubMed ID: 26995170
    [No Abstract]   [Full Text] [Related]  

  • 17. Take-home naloxone kits preventing overdose deaths.
    Eggertson L
    CMAJ; 2014 Jan; 186(1):17. PubMed ID: 24277710
    [No Abstract]   [Full Text] [Related]  

  • 18. Take-home naloxone in Australia and beyond.
    Olsen A; Dwyer R; Lenton S
    Drug Alcohol Rev; 2018 May; 37(4):437-439. PubMed ID: 29744978
    [No Abstract]   [Full Text] [Related]  

  • 19. Take-home naloxone possession among people who inject drugs in rural West Virginia.
    Allen ST; White RH; O'Rourke A; Grieb SM; Kilkenny ME; Sherman SG
    Drug Alcohol Depend; 2019 Nov; 204():107581. PubMed ID: 31574407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study.
    Seal KH; Thawley R; Gee L; Bamberger J; Kral AH; Ciccarone D; Downing M; Edlin BR
    J Urban Health; 2005 Jun; 82(2):303-11. PubMed ID: 15872192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.